Anticipated Shortage

GIOTRIF

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GIOTRIF in Canada?

A shortage of GIOTRIF 30MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated June 26, 2026), but it has not started yet.

When will GIOTRIF be available again?

The manufacturer's estimated resolution date is January 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file2 products

Expected resolution~4 months remaining (estimate)

Affected strength30MG

Last updated2026-06-26

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TEVA-AFATINIB

TEVA CANADA LIMITED

30MG · DIN 02514605

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

MAR-AFATINIB

MARCAN PHARMACEUTICALS INC

20MG · DIN 02517019

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2027-01-31

~4 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02415674

Strength

30MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

AFATINIB

Tier

Unrated

Last Updated

2026-06-26

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

DIN 02242119

250MG · DIN 02273322

20MCG · DIN 02247686

DIN 02419106

DIN 02231675

0.4MG · DIN 02270102